SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Spencer Ryan (Last) (First) (Middle) C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 (Street) BERKELEY CA 94710 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 05/21/2019	3. Issuer Name and Ticker or Trading Symbol DYNAVAX TECHNOLOGIES CORP [ DVAX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Co-President and Senior VP	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	20,707	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	02/24/2020	Common Stock	1,500	14.8	D
Stock Option (Right to Buy)	(1)	01/05/2021	Common Stock	4,500	31.4	D
Stock Option (Right to Buy)	(1)	01/31/2022	Common Stock	4,500	36.8	D
Stock Option (Right to Buy)	(1)	10/21/2022	Common Stock	2,000	42.6	D
Stock Option (Right to Buy)	(1)	02/05/2023	Common Stock	5,250	30.6	D
Stock Option (Right to Buy)	(1)	02/05/2024	Common Stock	3,500	16.7	D
Stock Option (Right to Buy)	(1)	02/08/2025	Common Stock	9,500	16	D
Stock Option (Right to Buy)	(2)	09/09/2025	Common Stock	2,000	30.49	D
Restricted Stock Unit	(3)	(3)	Common Stock	1,562	(3)	D
Restricted Stock Unit	(4)	(4)	Common Stock	6,375	(4)	D
Restricted Stock Unit	(5)	(5)	Common Stock	4,875	(5)	D
Stock Option (Right to Buy)	(6)	01/31/2025	Common Stock	56,000	16.45	D
Restricted Stock Unit	(7)	(7)	Common Stock	62,500	(7)	D

Explanation of Responses:

1. The shares subject to the option are fully vested and exercisable

2. This option grant will vest over four (4) years with one fourth (1/4) of the shares subject to the option vesting twelve months after the grant date of September 10, 2015, and one forty-eighth (1/48) of the shares subject to the option vesting each month thereafter.

3. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over four years with 1/4 vesting on each annual anniversary of February 5, 2016.

4. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 22, 2017.

5. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over two years with 1/2 vesting on each annual anniversary of June 2, 2017.

6. This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 1, 2018, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

7. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 22, 2019.

Remarks:

	/s/ Ryan Spencer	05/31/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.